417 related articles for article (PubMed ID: 30120123)
21. Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations.
Lara-Reyna S; Holbrook J; Jarosz-Griffiths HH; Peckham D; McDermott MF
Cell Mol Life Sci; 2020 Nov; 77(22):4485-4503. PubMed ID: 32367193
[TBL] [Abstract][Full Text] [Related]
22. Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr(-/-) mice.
Sajjan U; Thanassoulis G; Cherapanov V; Lu A; Sjolin C; Steer B; Wu YJ; Rotstein OD; Kent G; McKerlie C; Forstner J; Downey GP
Infect Immun; 2001 Aug; 69(8):5138-50. PubMed ID: 11447196
[TBL] [Abstract][Full Text] [Related]
23. F508del-CFTR increases intracellular Ca(2+) signaling that causes enhanced calcium-dependent Cl(-) conductance in cystic fibrosis.
Martins JR; Kongsuphol P; Sammels E; Dahimène S; Aldehni F; Clarke LA; Schreiber R; de Smedt H; Amaral MD; Kunzelmann K
Biochim Biophys Acta; 2011 Nov; 1812(11):1385-92. PubMed ID: 21907281
[TBL] [Abstract][Full Text] [Related]
24. Macrophages, but not neutrophils, are critical for proliferation of Burkholderia cenocepacia and ensuing host-damaging inflammation.
Mesureur J; Feliciano JR; Wagner N; Gomes MC; Zhang L; Blanco-Gonzalez M; van der Vaart M; O'Callaghan D; Meijer AH; Vergunst AC
PLoS Pathog; 2017 Jun; 13(6):e1006437. PubMed ID: 28651010
[TBL] [Abstract][Full Text] [Related]
25. Aberrant GSH reductase and NOX activities concur with defective CFTR to pro-oxidative imbalance in cystic fibrosis airways.
de Bari L; Favia M; Bobba A; Lassandro R; Guerra L; Atlante A
J Bioenerg Biomembr; 2018 Apr; 50(2):117-129. PubMed ID: 29524019
[TBL] [Abstract][Full Text] [Related]
26. Aggregates of mutant CFTR fragments in airway epithelial cells of CF lungs: new pathologic observations.
Du K; Karp PH; Ackerley C; Zabner J; Keshavjee S; Cutz E; Yeger H
J Cyst Fibros; 2015 Mar; 14(2):182-93. PubMed ID: 25453871
[TBL] [Abstract][Full Text] [Related]
27. Iron Homeostasis and Inflammatory Status in Mice Deficient for the Cystic Fibrosis Transmembrane Regulator.
Deschemin JC; Allouche S; Brouillard F; Vaulont S
PLoS One; 2015; 10(12):e0145685. PubMed ID: 26709821
[TBL] [Abstract][Full Text] [Related]
28. Lack of CFTR in skeletal muscle predisposes to muscle wasting and diaphragm muscle pump failure in cystic fibrosis mice.
Divangahi M; Balghi H; Danialou G; Comtois AS; Demoule A; Ernest S; Haston C; Robert R; Hanrahan JW; Radzioch D; Petrof BJ
PLoS Genet; 2009 Jul; 5(7):e1000586. PubMed ID: 19649303
[TBL] [Abstract][Full Text] [Related]
29. Increased susceptibility of Cftr-/- mice to LPS-induced lung remodeling.
Bruscia EM; Zhang PX; Barone C; Scholte BJ; Homer R; Krause DS; Egan ME
Am J Physiol Lung Cell Mol Physiol; 2016 Apr; 310(8):L711-9. PubMed ID: 26851259
[TBL] [Abstract][Full Text] [Related]
30. Specific resistance to Pseudomonas aeruginosa infection in zebrafish is mediated by the cystic fibrosis transmembrane conductance regulator.
Phennicie RT; Sullivan MJ; Singer JT; Yoder JA; Kim CH
Infect Immun; 2010 Nov; 78(11):4542-50. PubMed ID: 20732993
[TBL] [Abstract][Full Text] [Related]
31. The role of chloride anion and CFTR in killing of Pseudomonas aeruginosa by normal and CF neutrophils.
Painter RG; Bonvillain RW; Valentine VG; Lombard GA; LaPlace SG; Nauseef WM; Wang G
J Leukoc Biol; 2008 Jun; 83(6):1345-53. PubMed ID: 18353929
[TBL] [Abstract][Full Text] [Related]
32. Lack of cystic fibrosis transmembrane conductance regulator in CD3+ lymphocytes leads to aberrant cytokine secretion and hyperinflammatory adaptive immune responses.
Mueller C; Braag SA; Keeler A; Hodges C; Drumm M; Flotte TR
Am J Respir Cell Mol Biol; 2011 Jun; 44(6):922-9. PubMed ID: 20724552
[TBL] [Abstract][Full Text] [Related]
33. Immune responses in cystic fibrosis: are they intrinsically defective?
Ratner D; Mueller C
Am J Respir Cell Mol Biol; 2012 Jun; 46(6):715-22. PubMed ID: 22403802
[TBL] [Abstract][Full Text] [Related]
34. Neutrophil-mediated phagocytic host defense defect in myeloid Cftr-inactivated mice.
Ng HP; Zhou Y; Song K; Hodges CA; Drumm ML; Wang G
PLoS One; 2014; 9(9):e106813. PubMed ID: 25184794
[TBL] [Abstract][Full Text] [Related]
35. A cystic fibrosis respiratory epithelial cell chronically treated by miglustat acquires a non-cystic fibrosis-like phenotype.
Norez C; Antigny F; Noel S; Vandebrouck C; Becq F
Am J Respir Cell Mol Biol; 2009 Aug; 41(2):217-25. PubMed ID: 19131642
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological Correction of Cystic Fibrosis: Molecular Mechanisms at the Plasma Membrane to Augment Mutant CFTR Function.
Arora K; Naren AP
Curr Drug Targets; 2016; 17(11):1275-81. PubMed ID: 26648081
[TBL] [Abstract][Full Text] [Related]
37. Cystic fibrosis transmembrane conductance regulator in human muscle: Dysfunction causes abnormal metabolic recovery in exercise.
Lamhonwah AM; Bear CE; Huan LJ; Kim Chiaw P; Ackerley CA; Tein I
Ann Neurol; 2010 Jun; 67(6):802-8. PubMed ID: 20517942
[TBL] [Abstract][Full Text] [Related]
38. The low PLC-δ1 expression in cystic fibrosis bronchial epithelial cells induces upregulation of TRPV6 channel activity.
Vachel L; Norez C; Jayle C; Becq F; Vandebrouck C
Cell Calcium; 2015 Jan; 57(1):38-48. PubMed ID: 25477137
[TBL] [Abstract][Full Text] [Related]
39. Neutrophil extracellular traps are present in the airways of ENaC-overexpressing mice with cystic fibrosis-like lung disease.
Tucker SL; Sarr D; Rada B
BMC Immunol; 2021 Jan; 22(1):7. PubMed ID: 33478382
[TBL] [Abstract][Full Text] [Related]
40. Esc peptides as novel potentiators of defective cystic fibrosis transmembrane conductance regulator: an unprecedented property of antimicrobial peptides.
Ferrera L; Cappiello F; Loffredo MR; Puglisi E; Casciaro B; Botta B; Galietta LJV; Mori M; Mangoni ML
Cell Mol Life Sci; 2021 Dec; 79(1):67. PubMed ID: 34971429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
